* AngioDynamics Inc ANGO.OQ reported quarterly adjusted
earnings
of 2 cents per share for the quarter ended in May. The mean
expectation of four analysts for the quarter was for earnings of
2 cents per share.
* Revenue rose 4.7% to $91.07 million from a year ago;
analysts
expected $90.73 million.
* AngioDynamics Inc's reported EPS for the quarter was a
loss
of 54 cents.
* The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* AngioDynamics Inc shares had fallen by 4.7% this
quarter and
lost 27.8% so far this year.
* The company reported a quarterly loss of $21.47 million.
* Wall Street's median 12-month price target for
AngioDynamics Inc
is $15.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data July
12 at 01:30 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
May. 31 2023 0.02 0.02 Met
Feb. 28 2023 -0.01 -0.03 Missed
Nov. 30 2022 -0.01 0.01 Beat
Aug. 31 2022 -0.02 -0.06 Missed